NCT07603765

Brief Summary

This prospective observational clinical study aims to evaluate the clinical utility of Pressure Recording Analytical Method (PRAM)-based minimally invasive hemodynamic monitoring in patients undergoing cardiac ablation procedures. The study will be conducted in the cardiac catheterization laboratory of Istanbul University-Cerrahpaşa Cardiology Institute and will include 27 adult patients scheduled for catheter ablation. Written informed consent will be obtained from all participants, and the study will adhere to the principles of the Declaration of Helsinki.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
27

participants targeted

Target at below P25 for all trials

Timeline
7mo left

Started Apr 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress10%
Apr 2026Dec 2026

Study Start

First participant enrolled

April 30, 2026

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

May 4, 2026

Completed
18 days until next milestone

First Posted

Study publicly available on registry

May 22, 2026

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 15, 2026

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2026

Last Updated

May 22, 2026

Status Verified

May 1, 2026

Enrollment Period

7 months

First QC Date

May 4, 2026

Last Update Submit

May 21, 2026

Conditions

Keywords

catheter ablationanesthesiologyconscious Sedationdeep sedationhemodynamic monitoring

Outcome Measures

Primary Outcomes (1)

  • Change in Cardiac Output measured by PRAM during catheter ablation

    Cardiac output (L/min) measured using the PRAM-based monitoring system during catheter ablation procedures under non-operating room anesthesia.

    Intra-procedural (T0: before ablation, T1: during ablation, T2: after ablation)

Secondary Outcomes (8)

  • Change in Cardiac Index During Catheter Ablation

    Intra-procedural (T0: before ablation, T1: during ablation, T2: after ablation)

  • Change in Stroke Volume During Catheter Ablation

    Intra-procedural (T0: before ablation, T1: during ablation, T2: after ablation)

  • Change in Mean Arterial Pressure During Catheter Ablation

    Intra-procedural (T0: before ablation, T1: during ablation, T2: after ablation)

  • Change in Systemic Vascular Resistance During Catheter Ablation

    Intra-procedural (T0: before ablation, T1: during ablation, T2: after ablation)

  • Change in Stroke Volume Variation During Catheter Ablation

    Intra-procedural (T0: before ablation, T1: during ablation, T2: after ablation)

  • +3 more secondary outcomes

Interventions

Continuous beat-to-beat hemodynamic monitoring using the Pressure Recording Analytical Method (PRAM) via an invasive arterial line.

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients undergoing cardiac catheter ablation in an electrophysiology laboratory with minimally invasive hemodynamic monitoring.

You may qualify if:

  • Age ≥18 years
  • Patients scheduled for cardiac catheter ablation in the electrophysiology laboratory
  • Indication for ablation confirmed by a cardiologist
  • Ability to provide written informed consent
  • Planned invasive arterial blood pressure monitoring during the procedure

You may not qualify if:

  • Refusal or inability to provide informed consent
  • Failure to identify arrhythmogenic focus leading to cancellation of ablation procedure
  • Severe hemodynamic instability prior to procedure
  • Contraindication to invasive arterial catheterization
  • Incomplete hemodynamic data acquisition
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University-Cerrahpasa, Institute of Cardiology

Istanbul, Turkey (Türkiye)

RECRUITING

Study Officials

  • Kerem Erkalp

    Istanbul University-Cerrahpasa, Institute of Cardiology

    STUDY CHAIR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

May 4, 2026

First Posted

May 22, 2026

Study Start

April 30, 2026

Primary Completion (Estimated)

November 15, 2026

Study Completion (Estimated)

December 15, 2026

Last Updated

May 22, 2026

Record last verified: 2026-05

Locations